However, when results obtained from AD patients were compared to that from C2 (AD vs C2) (Figure 4c), the accumulation of CE was associated with an increased expression of SREBP-2 and APP and with a decrease of ABCA-1 and ACAT-1. The gene discussed is SREBF2; the disease is Alzheimer disease.